RUSSELL P. ROTHER,DOUGLAS L. SHERIDAN,PAUL P. TAMBURINI,YUCHUN ZHANG
申请号：
PT11775670
公开号：
PT2563813E
申请日:
2011.04.29
申请国别(地区):
PT
年份:
2015
代理人:
摘要：
The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement-associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospholipid syndrome, asthma, lupus nephritis, Goodpastures syndrome, and chronic obstructive pulmonary disease.
